Laureate, Selexis Expand Collaboration
Laureate Pharma (Laureate) and Selexis have continued their collaboration via a joint-marketing relationship. The expanded relationship provides streamlined access to a set of contract services to both the

Laureate Pharma (Laureate) and Selexis have continued their collaboration via a joint-marketing relationship. The expanded relationship provides streamlined access to a set of contract services to both the

The US Patent and Trademark Office (USPTO) has issued a patent to CyDex Pharmaceuticals (CyDex) entitled ‘Sulfoalkyl Ether Cyclodextrin Compositions.’ The patent, along with other previously issued technology

Rexam has reported the closure of its plastic packaging manufacturing plant in Nashua, New Hampshire. The closure is expected to occur in the fourth quarter of 2010. The

MonoSol Rx has entered into a new licensing and development agreement that grants the option to develop three new products with Strativa Pharmaceuticals (Strativa). Strativa has the option

Kollodis BioSciences (Kollodis) has entered into an exclusive distribution agreement with Cambridge Bioscience for the distribution of its MAPTrix ECM line of products for cell culture and related

Konica Minolta Sensing Americas (KMSA) has launched color measurement instrument, the CM-5 Spectrophotometer in the US. The CM-5 is a full featured, accurate and a totally standalone instrument

Bioject Medical Technologies (Bioject) has established a strategic alliance with MPI Research. It allows Bioject to gain access to a range of capabilities and resources needed to explore

Inverness Medical has entered into a distribution agreement with Epocal of Ottawa, Canada, to distribute its epoc blood analysis system for blood gas and electrolyte testing. The epoc

Cardium Therapeutics (Cardium) has planned to launch a new premium advanced skin care product line to promote foot health and comfort for podiatry patients. Cardium’s new MedPodium product

ImmuneRegen BioSciences (ImmuneRegen) has presented additional positive results from a recent study that evaluated its lead anti-influenza drug, Homspera, in ferrets. The study performed at a public University